Biofrontera AG

Home » Biofrontera AG

IPO

Biofrontera AG

They are an international biopharmaceutical company specializing in the development and commercialization of a platform of pharmaceutical products for the treatment of dermatological conditions and diseases caused primarily by exposure to sunlight that results in sun damage to the skin.

Symbol

BFRA

Final Price
$9.88

Final Shares
1,210,000

Effective Date
February 14, 2018

Underwriters
Benchmark

To view the prospectus for Biofrontera AG IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253